Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This investigational Traditional Chinese Medicine (TCM) mouthrinse, developed by researchers at The University of Hong Kong, contains a 5% aqueous extract of *Fructus mume* (also known as *Prunus mume* or Japanese apricot). It is specifically designed to improve oral health and treat gingivitis in patients undergoing orthodontic treatment with fixed appliances. The extract's primary antimicrobial activity is attributed to its organic acid content, which targets oral pathogens such as *Streptococcus mutans*. In a randomized, single-blind, parallel-controlled clinical trial (NCT01637948), the mouthrinse was shown to effectively reduce gingival bleeding and improve gingival health indices over a six-month period, performing comparably to essential oil-based rinses without significantly altering the overall oral microbial profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fructus mume extract mouthrinse.